ArticleAbdominal radiology (New York)2025
Quantitative PCCT imaging in differentiating adrenal adenomas from metastases: diagnostic performance and its clinical applications.
Article in Abdominal radiology (New York), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Understanding Photon-Counting CT: Physics, Detector Technology, and Image Reconstructions.Sensors (Basel, Switzerland) · 2026Review
- Differentiation of Fat-poor and Atypical Adrenal Adenomas from Metastases: MRI-based Radiomic, Radiologic, and Radiomic-radiologic Machine Learning Models.Current medical imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo evaluate the potential of Photon counting CT (PCCT) -derived iodine densities and Virtual-Non-Contrast (VNC) reconstructions for the differentiation between adrenal adenomas and adrenal metastases. MATERIALS AND
methodsThis retrospective study enrolled 53 PCCT scans of patients with adrenal lesions (29 adenomas, 24 metastases) including early-arterial (ea) and portal-venous (pv) contrast phase. Iodine maps and VNC reconstructions were calculated from the acquired sequences. Using the measured values, several parameters such as relative enhancement (RE), normalized iodine density (NID), and iodine to VNC ratio (IVR) were calculated. In the acquired image series, iodine maps and VNC reconstructions density values were evaluated (adrenal lesion, ipsilateral adrenal tissue, contralateral adrenal tissue, portal vein, descending aorta, inferior vena cava, subcutaneous adipose tissue, in the first lumbar vertebral body, surrounding air, and in the psoas muscle) and compared.
resultsIn total, the measured structures showed significant variation in density values due to different contrast phases and reconstructions. VNC reconstructions of portal-venous contrast phase showed significant differences in measured density mean values between adrenal adenomas and adrenal metastases (21.64 HU vs. 28.26 HU, p: 0.027, AUC: 0.68). No significant differences between metastases and adenomas were observed in iodine concentration, RE of ea, NID of ea and pv, as IVR of ea. Significant alterations were observed in RE of pv (p: 0.023, AUC: 0.7) and IVR of pv (pv: 0.029, AUC: 0.69).
conclusionThe recent study shows that PCCT derived VNC reconstructions of portal venous contrast phase can be used for reliable differentiation of adrenal adenomas and adrenal metastases and underlines the value of PCCT in oncological imaging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.